In today's global economy, China has become a force to be reckoned with. With the continued growth of China and the financial crisis across Europe and USA, the 21st century may well be marked as the era of China. The   huge governmental funding and enormous market size make China extremely attractive for business, particularly in the biomedical sector. Most recently the Chinese and Swedish governments have reached an agreement to  collaborate in the life science field. This marks great potential for the Swedish life science and biomedical companies. However doing business in China is a rather risky matter and the entry barrier is extremely high. Thus a good connection, understanding and knowledge about China is essential for doing business in China. At Channel Biomedix, we have a lot to offer in China:

• Years of experience of working in the market with excellent tracking record
  
• Extensive network and peer colleagues in various medical institutions and clinics
• Native Chinese speaking and capable of presenting science and technology to medical professional
• Active member of medical and scientific community in the area of diabetes and related diseases

The Japanese biomedical market is the second largest one in the world next to the United States. In spite of recent years recession, the market is still extremely attractive largely owing to its premium pricing level, well established medical care system and large market size. In addition, Japan's aging society makes it a long-term growth market for pharmaceuticals and medical devices. However making a success in Japan is rather a challenging task due to its protective nature, strict regulation process and competitive environment. At Biomedix, we have expertises who are experienced with the Japanese culture, business environment and networking. Together with the Greater China, it is one of our main markets in the Asia Pacific region. 

Fortune's first global 500 list of the world's largest corporations, published in 1995, was dominated by American and Japanese companies. Today we are seeing increasing number of companies coming from Asian countries which reflects a major power shifting in world. With the growing economic and financial difficulties in US and Europe in recent years, Asia as a whole has become more attractive than ever. It is known fact that many international companies have moved their facilities to Asia in aim to take an advantage of the market opportunity and business potential. However such an approach is rather difficult for many of the small to medium sized companies due to their immediate needs in Europe and the lacking of experience in Asia market. At Biomedix, our mission is to bring innovative technologies and products into the Asian market and we can help you to extend your innovation further.